KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Intangibles: 2009-2025

Historic Intangibles for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $3.9 billion.

  • Teva Pharmaceutical Industries' Intangibles fell 17.24% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year decrease of 17.24%. This contributed to the annual value of $4.4 billion for FY2024, which is 17.99% down from last year.
  • According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Intangibles is $3.9 billion, which was down 4.97% from $4.1 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Intangibles high stood at $8.4 billion for Q1 2021, and its period low was $3.9 billion during Q3 2025.
  • For the 3-year period, Teva Pharmaceutical Industries' Intangibles averaged around $4.9 billion, with its median value being $4.9 billion (2024).
  • Data for Teva Pharmaceutical Industries' Intangibles shows a maximum YoY decreased of 18.37% (in 2022) over the last 5 years.
  • Over the past 5 years, Teva Pharmaceutical Industries' Intangibles (Quarterly) stood at $7.5 billion in 2021, then decreased by 16.02% to $6.3 billion in 2022, then decreased by 14.08% to $5.4 billion in 2023, then decreased by 17.99% to $4.4 billion in 2024, then fell by 17.24% to $3.9 billion in 2025.
  • Its Intangibles was $3.9 billion in Q3 2025, compared to $4.1 billion in Q2 2025 and $4.2 billion in Q1 2025.